Advertisement
Screener

C4 Therapeutics, Inc. (CCCC) Patents: Active

C4 Therapeutics, Inc. Active Patents

41 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-05-12: Application 19205510; Invention ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR; Applicant C4 THERAPEUTICS, INC.; Status Patented Case.
  • 2024-12-13: Application 18980700; Invention THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF; Applicant C4 THERAPEUTICS, INC.; Status Patented Case.
  • 2024-12-09: Application 18973867; Invention N/; Applicant C4 THERAPEUTICS, INC.; Status Patented Case.
  • 2024-12-06: Application 18972557; Invention BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS; Applicant C4 THERAPEUTICS, INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2025-05-1219205510ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFRC4 THERAPEUTICS, INC.Patented Case2025-12-0212486290US20250270234A1
Christopher G. Nasveschuk
Martin Duplessis
Jae Young Ahn
Alexander W. Hird
Ryan E. Michael
Kiel Lazarski
Yanke Liang
Georg Jaeschke
Antonio Ricci
Annick Goergler
Daniel Rueher
United States
United States
United States
United States
United States
United States
United States
Switzerland
Switzerland
France
France
ALLEY, GENEVIEVE S
2024-12-1318980700THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAFC4 THERAPEUTICS, INC.Patented Case2025-12-0212486253US20250115580A1
Christopher G. Nasveschuk
Katrina L. Jackson
Yanke Liang
Martin Duplessis
Mark E. Fitzgerald
Cosimo Dolente
David Stephen Hewings
Daniel Hunziker
Daniela Krummenacher
Piergiorgio Francesco Tommaso Pettazzoni
Juergen Wichmann
United States
United States
United States
United States
United States
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
Germany
AULAKH, CHARANJIT
2024-12-0918973867N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATIONC4 THERAPEUTICS, INC.Patented Case2025-10-1412441740US20250101037A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Yanke Liang
Minsheng He
Martin Duplessis
Chi-Li Chen
United States
United States
United States
United States
United States
United States
United States
KIFLE, BRUCK
2024-12-0618972557BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERSC4 THERAPEUTICS, INC.Patented Case2025-09-2312421220US20250122179A1
Christopher G. Nasveschuk
Kiel Lazarski
Yanke Liang
Alexander W. Hird
Ning Yin
Andrew Charles Good
Hongwei Huang
Scott Joseph Eron
Gesine Kerstin Veits
United States
United States
United States
United States
United States
United Kingdom
United States
United States
United States
HABTE, KAHSAY
2024-04-2218642602C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATIONC4 THERAPEUTICS, INC.Patented Case2026-04-2112605450US20240398959A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Yanke Liang
Minsheng He
Kiel Lazarski
Gesine Kerstin Veits
Harit U. Vora
United States
United States
United States
United States
United States
United States
United States
United States
HABTE, KAHSAY
2023-09-1918370186DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENTC4 Therapeutics, Inc.Patented Case2025-07-2212365681US20240109889A1
Roger Norcross
Annick Goergler
Fabian Dey
Eric Andre Kusznir
Switzerland
Switzerland
Switzerland
Switzerland
VAJDA, KRISTIN ANN
2023-05-0818144800ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFRC4 Therapeutics, Inc.Patented Case2025-07-2912371442US20240076300A1
Christopher G. Nasveschuk
Martin Duplessis
Jae Young Ahn
Alexander W. Hird
Ryan E. Michael
Kiel Lazarski
Yanke Liang
Georg Jaeschke
Antonio Ricci
Annick Goergler
Daniel Rueher
United States
United States
United States
United States
United States
United States
United States
Switzerland
Switzerland
France
France
ALLEY, GENEVIEVE S
2023-04-1418134985TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4C4 Therapeutics, Inc.Patented Case2026-09-0812729193US20230339902A1
Christopher G. Nasveschuk
James A. Henderson
Moses Moustakim
Andrew Charles Good
David Proia
United States
United States
United States
United States
United States
DAHLIN, HEATHER RAQUEL
2023-03-0618117978SPIROCYCLIC COMPOUNDSC4 Therapeutics, Inc.Patented Case2026-06-2312662488US20240018156A1
Christopher G. Nasveschuk
Fabian Dey
Annick Goergler
Roger Norcross
Philipp Schmid
United States
Switzerland
France
Switzerland
Switzerland
SCHMITT, MICHAEL J
2023-02-0718106893ADVANTAGEOUS THERAPIES FOR DISORDERS MEDIATED BY IKAROS OR AIOLOSC4 Therapeutics, Inc.Patented Case2026-09-0112721852US20230190760A1
David Proia
James A. Henderson
Minsheng He
Andrew Charles Good
Andrew J. Phillips
United States
United States
United States
United States
United States
NOTTINGHAM, KYLE GREGORY
2023-02-0318105735COMPOUNDS FOR TARGETED DEGRADATION OF RETC4 Therapeutics, Inc.Patented Case2026-06-2312661410US20230233692A1
James A. Henderson
Christopher G. Nasveschuk
Kiel Lazarski
Victoria Garza
Moses Moustakim
Jae Young Ahn
Gesine Kerstin Veits
Morgan Welzel O'Shea
Ryan E. Michael
Jeremy L. Yap
Yanke Liang
Andrew Charles Good
Mark E. Fitzgerald
Robert T. Yu
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
BURKETT, DANIEL JOHN
2023-01-2418100992SPIROCYCLIC COMPOUNDSC4 Therapeutics, Inc.Patented Case2025-02-1812227504US20230416251A1
Christopher G. Nasveschuk
Fabian Dey
Annick Goergler
Bernd Kuhn
Roger Norcross
Stephan Roever
Philipp Schmid
United States
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
AULAKH, CHARANJIT
2022-12-1918084380BRAF DEGRADERSC4 Therapeutics, Inc.Patented Case2026-02-2412559492US20230145336A1
Christopher G. Nasveschuk
Martin Duplessis
Mark E. Fitzgerald
Victoria Garza
Andrew Charles Good
Katrina L. Jackson
Yanke Liang
Moses Moustakim
Morgan Welzel O'Shea
Gesine Kerstin Veits
Jeremy L. Yap
Robert T. Yu
Cosimo Dolente
David Stephen Hewings
Daniel Hunziker
Bernd Kuhn
Piergiorgio Francesco Tommaso Pettazzoni
Fabienne Ricklin
Claus Riemer
Juergen Wichmann
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
France
Germany
Germany
KUCKLA, ANNA GRACE
2022-12-1218079815DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2026-03-1012570626US20230357180A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Minsheng He
Kiel Lazarski
United States
United States
United States
United States
United States
JARRELL, NOBLE E
2022-10-1317965569COMPOUNDS FOR TARGETED DEGRADATION OF BRD9C4 Therapeutics, Inc.Patented Case2024-12-0312157735US20240051953A1
Christopher G. Nasveschuk
Rhamy Zeid
Ning Yin
Katrina L. Jackson
Gesine Kerstin Veits
Moses Moustakim
Jeremy L. Yap
United States
United States
United States
United States
United States
United States
United States
WELLS, LAUREN QUINLAN
2022-10-0317959144N/O-Linked Degrons and Degronimers for Protein DegradationC4 Therapeutics, Inc.Patented Case2024-12-3112180225US20230279023A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Yanke Liang
Minsheng He
Martin Duplessis
Chi-Li Chen
United States
United States
United States
United States
United States
United States
United States
KIFLE, BRUCK
2022-09-0117901775COMPOUNDS FOR TARGETED DEGRADATION OF BRD9C4 Therapeutics, Inc.Patented Case2024-07-3012049464US20230060334A1
Christopher G. Nasveschuk
Rhamy Zeid
Ning Yin
Katrina L. Jackson
Gesine Kerstin Veits
Moses Moustakim
Jeremy L. Yap
United States
United States
United States
United States
United States
United States
United States
WELLS, LAUREN QUINLAN
2022-08-0117878753DIHYDROQUINOLINONES FOR MEDICAL TREATMENTC4 Therapeutics, Inc.Patented Case2024-09-1712091397US20230192643A1
Roger Norcross
Adrian Britschgi
Fabian Dey
Annick Goergler
Eric Andre Kusznir
Moreno Attilio Wichert
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
BAHTA, MEDHANIT W
2022-06-1717843769ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFRC4 Therapeutics, Inc.Patented Case2023-06-1311673902US20230110648A1
Christopher G. Nasveschuk
Martin Duplessis
Jae Young Ahn
Alexander W. Hird
Ryan E. Michael
Kiel Lazarski
Yanke Liang
Georg Jaeschke
Antonio Ricci
Annick Goergler
Daniel Rueher
United States
United States
United States
United States
United States
United States
United States
Switzerland
Switzerland
France
France
ALLEY, GENEVIEVE S
2022-01-1417576582DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENTC4 Therapeutics, Inc.Patented Case2023-10-1711787802US20220289738A1
Roger Norcross
Annick Goergler
Fabian Dey
Eric Andre Kusznir
Switzerland
Switzerland
Switzerland
Switzerland
VAJDA, KRISTIN ANN
2021-12-0217541035COMPOUNDS FOR TARGETED DEGRADATION OF BRD9C4 Therapeutics, Inc.Patented Case2023-07-0411691972US20220098194A1
Christopher G. Nasveschuk
Rhamy Zeid
Ning Yin
Katrina L. Jackson
Gesine Kerstin Veits
Moses Moustakim
Jeremy L. Yap
United States
United States
United States
United States
United States
United States
United States
WELLS, LAUREN QUINLAN
2021-11-1117524558SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2024-07-3012048748US20230095223A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Yanke Liang
Kiel Lazarski
Ryan E. Michael
United States
United States
United States
United States
United States
United States
SHIAO, REI TSANG
2021-10-1117498617TRICYCLIC DEGRADERS OF IKAROS AND AIOLOSC4 Therapeutics, Inc.Patented Case2022-08-0911407732
James A. Henderson
Minsheng He
Andrew Charles Good
Andrew John Phillips
United States
United States
United States
United States
REESE, HEIDI L
2021-09-0217465583HETEROCYCLIC COMPOUNDS FOR MEDICAL TREATMENTC4 Therapeutics, Inc.Patented Case2026-01-2012528797US20230019060A1
Christopher G. Nasveschuk
Roger Norcross
Fabian Dey
Annick Goergler
Eric Andre Kusznir
United States
Switzerland
Switzerland
France
Switzerland
CHEN, PO-CHIH
2021-06-1817351935TARGETED PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2025-10-2812454521US20220372016A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Katrina L. Jackson
Minsheng He
Yanke Liang
Mark E. Fitzgerald
Victoria Garza
United States
United States
United States
United States
United States
United States
United States
United States
ANDERSON, REBECCA L
2021-02-0117164446HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2024-09-0312076405US20230014124A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Yanke Liang
Mark E. Fitzgerald
Minsheng He
Ryan E. Michael
United States
United States
United States
United States
United States
United States
United States
PATEL, SAGAR S
2020-12-1417121389SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2024-07-3012048747US20220313827A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Yanke Liang
Chi-li Chen
Martin Duplessis
Minsheng He
Kiel Lazarski
United States
United States
United States
United States
United States
United States
United States
United States
WILLIS, DOUGLAS M
2020-11-3017107781C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2024-05-2811992531US20220313826A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Yanke Liang
Minsheng He
Kiel Lazarski
Gesine Kerstin Veits
Harit U. Vora
United States
United States
United States
United States
United States
United States
United States
United States
HABTE, KAHSAY
2020-11-2417103621SPIROCYCLIC COMPOUNDSC4 Therapeutics, Inc.Patented Case2023-04-1111623929US20210070763A1
Christopher G. Nasveschuk
Fabian Dey
Annick Goergler
Roger Norcross
Philipp Schmid
United States
Switzerland
France
Switzerland
Switzerland
SCHMITT, MICHAEL J
2020-10-1617072896SPIROCYCLIC COMPOUNDSC4 Therapeutics, Inc.Patented Case2023-02-2111584748US20210032245A1
Christopher G. Nasveschuk
Fabian Dey
Annick Goergler
Bernd Kuhn
Roger Norcross
Stephan Roever
Philipp Schmid
United States
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
AULAKH, CHARANJIT
2020-09-2417031550CEREBLON BINDERS FOR THE DEGRADATION OF IKAROSC4 Therapeutics, Inc.Patented Case2023-09-1211753397US20210009559A1
James A. Henderson
Gesine Kerstin Veits
Minsheng He
Christopher G. Nasveschuk
Andrew J. Phillips
Andrew Charles Good
United States
United States
United States
United States
United States
United States
MCDOWELL, BRIAN E
2020-05-2216882236SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2021-11-3011185592US20210106688A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Yanke Liang
Kiel Lazarski
Ryan E. Michael
United States
United States
United States
United States
United States
United States
SHIAO, REI TSANG
2020-05-1416874475DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2022-12-1311524949US20220251061A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Minsheng He
Kiel Lazarski
United States
United States
United States
United States
United States
JARRELL, NOBLE E
2020-05-1116872225HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2021-02-0210905768
Andrew J. Phillips
Chris G. Nasveschuk
James A. Henderson
Yanke Liang
Mark E. Fitzgerald
Minsheng He
Ryan E. Michael
United States
United States
United States
United States
United States
United States
United States
SACKEY, EBENEZER O
2020-03-0416809345DIHYDROQUINOLINONES FOR MEDICAL TREATMENTC4 Therapeutics, Inc.Patented Case2022-08-0211401256US20200207733A1
Roger Norcross
Adrian Britschgi
Fabian Dey
Annick Goergler
Eric Andre Kusznir
Moreno Attilio Wichert
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
BAHTA, MEDHANIT W
2020-03-0416809336GLUTARIMIDES FOR MEDICAL TREATMENTC4 Therapeutics, Inc.Patented Case2023-10-3111802131US20200207783A1
Roger Norcross
Annick Goergler
Philipp Schmid
Fabian Dey
Eric Andre Kusznir
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
SHTERENGARTS, SAMANTHA L
2020-03-0416809325DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENTC4 Therapeutics, Inc.Patented Case2022-02-2211254672US20200207764A1
Roger Norcross
Annick Goergler
Fabian Dey
Eric Andre Kusznir
Switzerland
Switzerland
Switzerland
Switzerland
VAJDA, KRISTIN ANN
2019-12-1916721650N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2022-10-0411459335US20200140456A1
Andrew J. Phillips
Christopher G. Nasveschuk
James A. Henderson
Yanke Liang
Minsheng He
Martin Duplessis
Chi-Li Chen
United States
United States
United States
United States
United States
United States
United States
KIFLE, BRUCK
2018-11-0916186341C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2020-12-0110849982US20190076542A1
Andrew J. Phillips
Chris G. Nasveschuk
James A. Henderson
Yanke Liang
Minsheng He
Kiel Lazarski
Gesine Kerstin Veits
Harit U. Vora
United States
United States
United States
United States
United States
United States
United States
United States
SACKEY, EBENEZER O
2018-11-0916186339HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2020-05-1210646575US20190076541A1
Andrew J. Phillips
Chris G. Nasveschuk
James A. Henderson
Yanke Liang
Mark E. Fitzgerald
Minsheng He
Ryan E. Michael
United States
United States
United States
United States
United States
United States
United States
SACKEY, EBENEZER O
2018-11-0916186334SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATIONC4 Therapeutics, Inc.Patented Case2020-05-2610660968US20190076540A1
Andrew J. Phillips
Chris G. Nasveschuk
James A. Henderson
Yanke Liang
Kiel Lazarski
Ryan E. Michael
United States
United States
United States
United States
United States
United States
SHIAO, REI TSANG

Similar stocks

Stock NameCountryMarket CapPE Ratio
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
AGENUS INC (AGEN)United States$0.383B1.41
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60